Written by Klarity Editorial Team
Published: Jul 15, 2026

Last updated: July 15, 2026
Key 2026 update for West Virginia: West Virginia Senate Bill 267 (2024) requires all Cigna WV prior authorization requests to be submitted electronically through Availity. Paper PA forms are no longer accepted for Cigna commercial plans in West Virginia. If your provider submits a paper PA, it will be rejected — confirm your provider uses Availity before scheduling. See if Klarity may help with your depression treatment →
Depression is one of the most common mental health conditions in the United States, affecting an estimated 21 million adults each year. For West Virginians covered by Cigna, understanding what your plan may cover — from therapy and medication to intensive outpatient programs — can make a significant difference in getting the care you need. This guide explains how Cigna may cover depression treatment in West Virginia in 2026, including formulary details for your pharmacy benefit manager (Express Scripts/ESI), prior authorization requirements, and your rights under West Virginia’s mental health parity law.
Cigna commercial health plans in West Virginia typically include coverage for depression treatment as a covered benefit. Under the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and West Virginia’s state parity statute (W. Va. Code § 33-25-8r et seq.), Cigna is generally required to cover mental health conditions — including major depressive disorder, persistent depressive disorder, and related conditions — on terms no more restrictive than comparable medical and surgical benefits.
In practice, this may mean:
Coverage specifics vary by your Cigna plan type. Always verify your individual benefits before starting treatment.
Cigna uses Express Scripts (ESI) as its pharmacy benefit manager for most commercial plans in West Virginia. The ESI formulary organizes covered medications into tiers, which determine your out-of-pocket cost at the pharmacy. Below is a general overview of how common depression medications may be tiered on the ESI formulary in 2026.
| Medication | Drug Class | Typical ESI Tier | Prior Authorization |
|---|---|---|---|
| Sertraline (generic Zoloft) | SSRI | Tier 1–2 | Generally no PA |
| Fluoxetine (generic Prozac) | SSRI | Tier 1–2 | Generally no PA |
| Escitalopram (generic Lexapro) | SSRI | Tier 1–2 | Generally no PA |
| Citalopram (generic Celexa) | SSRI | Tier 1–2 | Generally no PA |
| Venlafaxine XR (generic Effexor XR) | SNRI | Tier 1–2 | Generally no PA |
| Duloxetine (generic Cymbalta) | SNRI | Tier 1–2 | Generally no PA |
| Bupropion XL (generic Wellbutrin XL) | NDRI | Tier 1–2 | Generally no PA |
| Mirtazapine (generic Remeron) | NaSSA | Tier 1–2 | Generally no PA |
| Trazodone (generic) | SARI | Tier 1–2 | Generally no PA |
| Amitriptyline / Nortriptyline | TCA | Tier 1–2 | Generally no PA |
| Brand SSRIs / SNRIs (Lexapro, Effexor XR, Cymbalta brand) | SSRI / SNRI (brand) | Tier 3–4 | Step therapy typically required |
| Trintellix (vortioxetine) | Multimodal antidepressant | Tier 3–4 | PA likely required |
| Auvelity (dextromethorphan-bupropion) | NMDA antagonist | Tier 3–4 | PA likely required |
| Spravato (esketamine nasal spray) | NMDA antagonist (nasal) | Specialty tier | PA + REMS enrollment required (Schedule III) |
Formulary tiers and PA requirements may vary by specific Cigna plan. Always verify coverage with Cigna at 1-800-244-6224 or via myCigna.com before filling a prescription.
Step therapy — sometimes called “fail first” — requires that a patient try one or more lower-cost medications before Cigna will approve coverage for a higher-tier drug. For depression, this typically means your provider may need to document that you tried a generic SSRI or SNRI before Cigna will approve coverage for a brand-name antidepressant, Trintellix, or Auvelity. Step therapy requirements are plan-specific; your provider can initiate a step therapy exception request if clinically appropriate.
West Virginia law (W. Va. Code § 60A-4-403a) requires electronic prescribing for all controlled substances — a broader mandate than most states, which apply EPCS only to Schedule II drugs. For depression treatment, the key EPCS consideration is as follows:
The vast majority of depression medications — including all SSRIs (sertraline, fluoxetine, escitalopram, citalopram, paroxetine), SNRIs (venlafaxine, duloxetine, desvenlafaxine), bupropion, mirtazapine, trazodone, TCAs, Trintellix, and Auvelity — are non-scheduled controlled substances. W. Va. Code § 60A-4-403a does not apply to non-scheduled drugs. For standard antidepressants, EPCS is entirely inapplicable — these medications may be prescribed by paper, phone, or electronic method with no EPCS requirement.
Spravato (esketamine nasal spray), used for treatment-resistant depression and major depressive disorder with suicidal ideation, is classified as a Schedule III controlled substance. Under W. Va. Code § 60A-4-403a’s all-controlled-substances EPCS mandate, Spravato prescriptions require electronic prescribing in West Virginia.
However, Spravato is administered exclusively in certified healthcare settings under the FDA’s REMS (Risk Evaluation and Mitigation Strategy) program — patients self-administer a single dose under direct medical supervision and observation for at least two hours at each session. The EPCS compliance for Spravato is handled at the treatment facility level by the certified prescriber and pharmacy. Patients do not need to manage EPCS logistics themselves. If your provider is referring you for Spravato, confirm the facility is REMS-certified and that Cigna has issued prior authorization before your first session.
West Virginia Senate Bill 267 (2024) requires all Cigna commercial plan PA requests to be submitted electronically through the Availity provider portal. Providers who attempt to submit paper prior authorization forms will have those requests rejected.
West Virginia’s mental health parity statute (W. Va. Code § 33-25-8r et seq.) generally requires that Cigna’s coverage for mental health conditions — including depression — be no more restrictive than coverage for comparable medical and surgical conditions. This applies to:
West Virginia’s § 33-25-8r applies to fully insured commercial plans regulated by the West Virginia Insurance Commissioner. Many large employers in West Virginia — particularly in the energy, chemical, manufacturing, and government contracting sectors — self-fund their employee health plans under ERISA. Self-funded ERISA plans are regulated by the federal government (U.S. Department of Labor) and are generally exempt from state parity requirements, though they remain subject to federal MHPAEA. If you are unsure whether your employer’s Cigna plan is fully insured or self-funded, contact your HR department or Cigna member services.
Cigna offers several plan types in West Virginia, and the coverage rules — especially referral requirements — may differ by plan:
Before beginning any new depression treatment or filling a new prescription, complete these steps:
Klarity Health connects patients in West Virginia with licensed providers who specialize in depression treatment. With a network of 2,000+ licensed providers across telehealth and in-person care, Klarity’s providers are experienced with Cigna prior authorization workflows, ESI formulary requirements, and West Virginia’s Availity PA submission mandate under SB 267.
Klarity providers are fully EPCS-compliant for all controlled substances. For standard antidepressant prescribing (SSRIs, SNRIs, bupropion, mirtazapine, and similar), EPCS requirements do not apply — your prescription may be sent to your pharmacy via standard electronic, paper, or phone methods.
Check if Klarity’s depression treatment services may work for your Cigna plan →
It depends on your plan type. Most Cigna employer plans in West Virginia are Open Access Plus (OAP), which typically does not require a referral to see a psychiatrist, therapist, or other mental health specialist. However, HMO plans generally require a referral from a primary care physician before you may see a mental health specialist. Check your plan documents or call 1-800-244-6224 to confirm your plan type and referral requirements.
For generic first-line antidepressants such as sertraline, fluoxetine, escitalopram, venlafaxine XR, duloxetine, bupropion XL, and mirtazapine, Cigna/ESI typically does not require prior authorization — these are generally Tier 1–2 on the ESI formulary. Brand-name antidepressants, Trintellix, and Auvelity typically require step therapy documentation or PA. Spravato requires full PA plus REMS certification. Your provider can initiate any required PA through Availity.
No. Standard antidepressants — including all SSRIs, SNRIs, bupropion, mirtazapine, trazodone, TCAs, Trintellix, and Auvelity — are non-scheduled substances. West Virginia’s EPCS mandate (W. Va. Code § 60A-4-403a) applies to controlled substances only. Non-scheduled antidepressants may be prescribed by any legal method. Spravato (Schedule III) is the only depression medication that triggers WV’s EPCS requirement, and compliance is managed at the REMS-certified treatment facility, not by the patient.
West Virginia’s mental health parity law (W. Va. Code § 33-25-8r et seq.) applies to fully insured commercial plans regulated by the West Virginia Insurance Commissioner. If your Cigna plan is purchased through the ACA Marketplace or provided by a small-to-mid-sized employer that fully insures its coverage, the state parity law likely applies. If your employer self-funds its health plan under ERISA (common among large WV employers in energy, manufacturing, and government contracting), the plan is generally exempt from the state parity statute but remains subject to federal MHPAEA. Contact Cigna member services or your HR department to confirm your plan type.
You have the right to appeal a PA denial. In West Virginia, you typically have up to 60 days after receiving a denial to file a formal internal appeal with Cigna. If the internal appeal is unsuccessful, you may request an independent external review. Your provider can submit a peer-to-peer review request — often effective for step therapy exceptions involving newer medications like Trintellix or Auvelity. For urgent clinical situations, request an expedited appeal (typically resolved within 72 hours). If you believe a denial violates your parity rights, you may file a complaint with the West Virginia Insurance Commissioner at 1-888-879-9842 (fully insured plans) or the U.S. DOL EBSA at 1-866-444-3272 (self-funded ERISA plans).
Yes. West Virginia law requires parity between in-person and telehealth mental health services for state-regulated plans. Cigna typically covers telehealth therapy and psychiatric medication management visits at the same cost-sharing as in-person care for equivalent services. Confirm telehealth coverage and any platform requirements with Cigna member services before your first virtual appointment.
Disclaimer: This article is for informational purposes only and does not constitute legal, medical, or insurance advice. Coverage details described herein reflect general ESI formulary and Cigna policy information as of July 2026 and may vary significantly by specific plan, employer, and individual circumstances. Coverage for depression treatment — including specific medications, therapy visits, and PA requirements — may vary by plan. Always verify your individual benefits by contacting Cigna at 1-800-244-6224 or visiting myCigna.com before starting treatment or filling a prescription. Klarity Health is not affiliated with Cigna or Express Scripts.
Find the right provider for your needs — select your state to find expert care near you.